(Q52935226)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16409193%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16409193%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16409193%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Ribel M

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16409193%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Herold DA

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16409193%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 February 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16409193%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16409193%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16409193%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16409193%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

181-184

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16409193%20AND%20SRC:MED&resulttype=core&format=json

The burden of atopy and asthma in children

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.00959.X

Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.00959.X

Severe oral allergy syndrome and anaphylactic reactions caused by a Bet v 1- related PR-10 protein in soybean, SAM22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.00959.X

Two Regions of Down-Regulation in the IgE-Mediated Signaling Pathway in Human Basophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.00959.X

Loss of syk kinase during IgE-mediated stimulation of human basophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.00959.X

Is sublingual immunotherapy clinically effective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.00959.X

Safety of sublingual-swallow immunotherapy in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.00959.X

Noninjection routes for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.00959.X

Allergic rhinitis and its impact on asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.00959.X